Show simple item record

dc.contributor.authorOzturk, I. I.en
dc.contributor.authorMetsios, A. K.en
dc.contributor.authorFilimonova-Orlova, S.en
dc.contributor.authorKourkoumelis, Nikolaosen
dc.contributor.authorHadjikakou, Sotiris K.en
dc.contributor.authorManos, Manolis J.en
dc.contributor.authorTasiopoulos, Anastasios J.en
dc.contributor.authorKarkabounas, Spyridon Chen
dc.contributor.authorMilaeva, E. R.en
dc.contributor.authorHadjiliadis, Nicken
dc.creatorOzturk, I. I.en
dc.creatorMetsios, A. K.en
dc.creatorFilimonova-Orlova, S.en
dc.creatorKourkoumelis, Nikolaosen
dc.creatorHadjikakou, Sotiris K.en
dc.creatorManos, Manolis J.en
dc.creatorTasiopoulos, Anastasios J.en
dc.creatorKarkabounas, Spyridon Chen
dc.creatorMilaeva, E. R.en
dc.creatorHadjiliadis, Nicken
dc.date.accessioned2019-11-21T06:21:52Z
dc.date.available2019-11-21T06:21:52Z
dc.date.issued2012
dc.identifier.issn1054-2523
dc.identifier.urihttp://gnosis.library.ucy.ac.cy/handle/7/55933
dc.description.abstractCrystals of the [SbBr3(MMBZT)2] (1) complex (MMBZT = N-methyl-2- mercaptobenzothiazole) were grown from acetonitrile/methanol of the filtrate derived from the reaction between 3-methyl-2-mercaptobenzo thiazole (MMBZT) in methanol, with antimony(III) bromide in acetonitrile. The crystal structure of 1 (C16H14 Br3N2S4Sb) was determined by X-ray diffraction at 100 (2) K, in space group P-1, with a = 10.738(2) A ̊ , b = 11.387(3) A ̊ , c = 11.439(3) A ̊ , a = 62.764°, b = 63.36 (2), c = 85.074(2), and Z = 2. The geometry around the metal center of complex 1 is square pyramidal, with two sulfur atoms from thione ligands and three bromide anions around Sb(III). Complex is monomer. The equatorial plane is formed by two sulfur and two bromide atoms in complex, in a cis-S, cis-Br arrangement. The in vitro cytotoxicity against leiomyosarcoma cells (LMS) of antimony(III) bromide complexes with thioamide ligands with formulae: [SbBr3(MMBZT)2] (1), [SbBr3(TU)2] (2), [SbBr3(MMI)2] (3), {[SbBr2(MBZIM)4][Br]-H2O} (4), {[SbBr2(l2-Br) (MMBZIM)2]2} (5), {[SbBr2(l2-Br)(EtMBZIM)2]2°MeOH} (6), {[SbBr3(l2-S-tHPMT)(tHPMT)]n} (7), {[SbBr2(l2-Br) (PYT)2)n} (8), {[SbBr2(l2-Br)(MTZD)2]n} (9), and {[SbBr5]2-[(PMTH2)2]} (10) (where TU = thiourea, MMI = methylimidazole, MBZIM = 2-mercaptobenzimidazole, MMBZIM = 2-mercapto-5-methyl-βenzimidazole, EtMBZIM = 5-ethoxy-2-mercaptobenzimidazole, tHPMT = 2-mercapto-3,4,5,6- tetrahydro-pyrimidine, PYT = 2-mercaptopyridine, MTZD = 2-mercapto-thiazolidine, and PMTH = 2-mercaptopyrimidine) were evaluated. Complex 8 shows the strongest activity against LMS cells with IC50 value 1.7 ± 0.1 μL. The results are compared with their activity against human cervix carcinoma cell lines. Complexes 1, 6-9 were also tested for their inhibitory activity upon the catalytic peroxidation of linoleic acid to hydroperoxylinoleic acid by the enzyme lipoxygenase. Computational studies using multivariate linear regression and considering biological results (50% inhibitory concentration, IC 50) as dependent variables derived a theoretical equation for IC50 values of the complexes studied. The calculated IC50 values are compared adequately with the experimental inhibitory activity of the complexes measured. © Springer Science+Business Media, LLC 2011.en
dc.sourceMedicinal Chemistry Researchen
dc.source.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-84871408032&doi=10.1007%2fs00044-011-9905-9&partnerID=40&md5=50d89c60fec820537590ae2fb0e13216
dc.subjectarticleen
dc.subjecthumanen
dc.subjectantineoplastic activityen
dc.subjectleiomyosarcomaen
dc.subjectlipid peroxidationen
dc.subjectcancer cellen
dc.subjecthuman cellen
dc.subjectin vitro studyen
dc.subjectcrystal structureen
dc.subjectcrystallizationen
dc.subjectX ray diffractionen
dc.subjectantimony derivativeen
dc.subjectconcentration responseen
dc.subjectstructure activity relationen
dc.subjectcytotoxicityen
dc.subjectIC 50en
dc.subjectbiological activityen
dc.subjectanionen
dc.subjectlinoleic aciden
dc.subject3-Methyl-2-mercaptobenzothiazoleen
dc.subjectAntimony(III) bromide complexesen
dc.subjectAntitumor activityen
dc.subjectatomen
dc.subjectbenzothiazole derivativeen
dc.subjectBioinorganic medicinal chemistryen
dc.subjectbromine derivativeen
dc.subjectLipoxygenaseen
dc.subjectuterine cervix carcinomaen
dc.titleStudy on single crystal structure of the antimony(III) bromide complex with 3-methyl-2-mercaptobenzothiazole and biological activity of some antimony(III) bromide complexes with thioamidesen
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1007/s00044-011-9905-9
dc.description.volume21
dc.description.issue11
dc.description.startingpage3523
dc.description.endingpage3531
dc.author.faculty002 Σχολή Θετικών και Εφαρμοσμένων Επιστημών / Faculty of Pure and Applied Sciences
dc.author.departmentΤμήμα Χημείας / Department of Chemistry
dc.type.uhtypeArticleen
dc.description.notes<p>Cited By :13</p>en
dc.source.abbreviationMed.Chem.Res.en
dc.contributor.orcidTasiopoulos, Anastasios J. [0000-0002-4804-3822]
dc.contributor.orcidHadjikakou, Sotiris K. [0000-0001-9556-6266]
dc.gnosis.orcid0000-0002-4804-3822
dc.gnosis.orcid0000-0001-9556-6266


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record